Burger King Primed for GLP-1 Shift -- Market Talk

Dow Jones
2025/12/03

0914 ET - Restaurant executives are watching for signs of slower sales as more Americans take GLP-1 weight loss drugs, but Burger King owner Restaurant Brands International thinks it's prepared to meet any demand shift. Weight-loss drug users often seek out protein while using the medications, and Burger King's products are protein rich, CEO Josh Kobza said during an investor event. The chain's Double Cheeseburger is a smaller size with a high meat to bread ratio, making it a potential draw for GLP-1 users, Kobza says. (heather.haddon@wsj.com; @heatherhaddon)

(END) Dow Jones Newswires

December 03, 2025 09:15 ET (14:15 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10